How High Could IBIT Go?
Recently, a surprising number of billionaire hedge fund managers have…
Buy
54
PTGX Quote, Financials, Valuation and Earnings
Last price:
$48.35
Seasonality move
:
13.71%
Day range:
$47.09 - $48.80
52-week range:
$24.22 - $60.60
Dividend yield:
0%
P/E ratio:
11.64x
P/S ratio:
7.12x
P/B ratio:
4.44x
Volume:
664.5K
Avg. volume:
1.4M
1-year change:
68.96%
Market cap:
$3B
Revenue:
$434.4M
EPS (TTM):
$4.20
Earnings Data
Next earnings date for PTGX
May 07
2025
Most recent earnings per share
$1.98
Beat by $1.73
(Feb 21/2025)
Consensus Estimate
$0.25
(Feb 21/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PTGX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $6.6M | -- | -- | -$0.53 | -- |
| 05/07/2025 | Q1 | $30.4M | -- | -- | $0.11 | -- |
| 02/21/2025 | Q4 | $56.6M | $170.6M | $1.98 | $0.25 | $1.73 |
| 11/07/2024 | Q3 | $1.8M | $4.7M | -$0.54 | -$0.53 | -$0.01 |
| 08/06/2024 | Q2 | $6.7M | $4.2M | -$0.50 | -$0.41 | -$0.09 |
| 05/07/2024 | Q1 | $120M | $255M | $3.26 | $1.60 | $1.66 |
| 02/27/2024 | Q4 | $30M | $60M | $0.44 | -$0.18 | $0.62 |
| 11/02/2023 | Q3 | -- | -- | -$0.58 | -$0.70 | $0.12 |
| 08/03/2023 | Q2 | -- | -- | -$0.68 | -$0.66 | -$0.02 |
| 05/04/2023 | Q1 | -- | -- | -$0.67 | -$0.70 | $0.03 |
| 03/15/2023 | Q4 | -- | -- | -$0.69 | -$0.61 | -$0.08 |
| 11/08/2022 | Q3 | -- | -- | -$0.64 | -$0.82 | $0.18 |
| 08/04/2022 | Q2 | -- | -- | -$0.84 | -$0.98 | $0.14 |
| 05/04/2022 | Q1 | -- | -- | -$0.43 | -$0.60 | $0.17 |
| 02/28/2022 | Q4 | -- | -- | -$0.77 | -$0.76 | -$0.01 |
| 11/03/2021 | Q3 | -- | -- | -$0.70 | -$0.66 | -$0.04 |
| 08/04/2021 | Q2 | -- | -- | -$0.69 | -$0.53 | -$0.16 |
| 05/04/2021 | Q1 | -- | -- | -$0.54 | -$0.57 | $0.02 |
| 03/10/2021 | Q4 | -- | -- | -$0.48 | -$0.47 | -$0.01 |
| 11/04/2020 | Q3 | -- | -- | -$0.21 | -$0.56 | $0.35 |
| 08/06/2020 | Q2 | -- | -- | -$0.59 | -$0.59 | -$0.01 |
| 05/07/2020 | Q1 | -- | -- | -$0.72 | -$0.68 | -$0.04 |
| 03/10/2020 | Q4 | -- | -- | -$0.63 | -$0.70 | $0.07 |
| 11/06/2019 | Q3 | -- | -- | -$0.61 | -$0.73 | $0.12 |
| 08/07/2019 | Q2 | -- | -- | -$1.18 | -$0.27 | -$0.91 |
| 05/08/2019 | Q1 | -- | -- | -$0.58 | -$0.63 | $0.05 |
| 03/12/2019 | Q4 | -- | -- | -$0.57 | -$0.47 | -$0.10 |
| 11/06/2018 | Q3 | -- | -- | -$0.38 | -$0.33 | -$0.05 |
| 08/07/2018 | Q2 | -- | -- | -$0.41 | -$0.29 | -$0.12 |
| 05/09/2018 | Q1 | -- | -- | -$0.36 | -$0.24 | -$0.12 |
| 03/07/2018 | Q4 | -- | -- | -$0.15 | -$0.37 | $0.22 |
| 11/06/2017 | Q3 | -- | -- | -$0.29 | -$0.61 | $0.32 |
| 08/08/2017 | Q2 | -- | -- | -$0.89 | -$0.81 | -$0.08 |
| 03/31/2017 | Q1 | -- | -- | -$0.84 | -$0.60 | -$0.25 |
Protagonist Therapeutics Earnings Questions
-
How Much did Protagonist Therapeutics Generate in Revenue Last Quarter?
Protagonist Therapeutics reported $170.6M worth of top line sales in its most recent quarter.
-
Did Protagonist Therapeutics Beat Earnings Last Quarter?
Protagonist Therapeutics announced earnings per share of $1.98 which represents a beat of analyst forecast a $0.25 per share.
-
Is Protagonist Therapeutics Profitable?
Protagonist Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Protagonist Therapeutics EPS Next Year?
Protagonist Therapeutics's earnings are forecast to decrease from $4.23 per share to $2.63 per share next year representing a decrease of -59.85%.
-
When is Protagonist Therapeutics's Earnings Date?
Protagonist Therapeutics's next earnings date is May 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Raymond James Stock a Buy, Sell or Hold?
Raymond James Financial (NYSE:RJF) is one of America’s large financial…
Is JHX Stock a Buy Sell or Hold?
James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 31
Ajinomoto [AJINY] is down 2.15% over the past day.
Sell
40
RGC alert for Mar 31
Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.
Buy
69
AGX alert for Mar 31
Argan [AGX] is down 4.98% over the past day.
